Patent details

Basic Information

Publication number:

EP1442133

PCT Application Number:

PCT/US/2002/001248

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP027041474

PCT Publication Number:

WO/2002/064735

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of Mirtazapine for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4

French Title of Invention:

Utilisation de Mirtazapine pour améliorer la réponse thérapeutique des humains ayant la dépression principale et portant le gène pour l'apolipoprotein E4

German Title of Invention:

Verwendung von Mirtazapin zur Verbesserung der Behandlung von Menschen mit starken Depressionen, welche Träger des Gens für Apolipoprotein E4 sind.

SPC Number:

Dates

Filing date:

12/02/2002

Grant date:

12/12/2007

EP Publication Date:

12/12/2007

PCT Publication Date:

22/08/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/08/2004

EP B1 Publication Date:

12/12/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/02/2008

Expiration date:

12/02/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/02/2002

 

 

Name:

N.V. Organon

Address:

Kloosterstraat 6, 5349 AB Oss, Netherlands (NL)

Inventor

1

Name:

MURPHY Greer, M.

Address:

United States (US)

2

Name:

SCHATZBERG Alan, F.

Address:

United States (US)

Priority

1

Priority Number:

780512

Priority Date:

12/02/2001

Priority Country:

United States (US)

2

Priority Number:

10087

Priority Date:

03/12/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C12Q 1/68;

Filing date	Document type	Number of pages